肝脏脑病的医疗负担 肝脏脑病的医疗负担
Kevin B Harris1, Humberto C Gonzalez2, Stuart C Gordon2
1Division of Gastroenterology and Hepatology, Henry Ford Health, Detroit, MI, USA.
Clinics in liver disease
|March 28, 2024
概括
肝硬化症的并发症肝硬化症严重负担患者和护理人员. 慢性肝病的流行率上升将加剧这种医疗保健挑战.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 公共卫生 公共卫生
背景情况:
- 肝脏脑病是肝硬化的一个常见并发症.
- 它给患者和护理人员带来了相当大的医疗负担.
- 慢性肝病的患病率正在增加.
研究的目的:
- 总结一下与肝脏脑病相关的医疗负担.
- 突出肝脏脑病对患者和护理人员的影响.
- 预测这个医疗保健挑战的未来增长.
主要方法:
- 文献综述和综合有关肝脏脑病的现有数据.
- 分析与条件相关的直接和间接成本.
- 检查患者的结果,包括住院和护理需求.
主要成果:
- 肝脑病导致显著的直接和间接成本.
- 患者会遇到诸如落,无法工作或驾驶等风险.
- 住院,再住院和亚急性护理是常见的,通常需要进行肝移植.
结论:
- 肝脑病症代表着越来越大的医疗保健负担.
- 慢性肝病的患病率越来越高,加剧了这个问题.
- 有效的管理策略对于降低成本和改善患者结果至关重要.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
60
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
60
Hepatic Drug Excretion: Enterohepatic Cycling
1.5K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.5K
Chronic Pancreatitis II: Collaborative Care
86
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
86
Diseases of the Liver and Gallbladder
534
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
534
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
118
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Most drugs undergo restrictive clearance, which is proportional to the...
118
Hepatic Drug Clearance: Effect of Protein Binding
194
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
194


